Marks talks OTP staffing, gene therapies, and more

Regulatory NewsRegulatory NewsAdvanced therapies/cell and gene therapyChemistry, Manufacturing and Controls (CMC)Clinical TrialsRegulatory Intelligence/PolicyUnited States